Je was op zoek naar: cyclo (Engels - Maltees)

fluoxetine, allopurinol, sympatholytics, cyclo-, tro-and iphosphamides,
fluoxetine, allopurinol, simpatolitiċi, cyclo-, tro-and iphosphamides,

the cyclo-oxygenase enzyme (cox) is present in two isoforms.
l-enzima cyclo-oxygenase (cox) hija preżenti f’żewġ isoformi.

it works by blocking an enzyme called cyclo-oxygenase 2 (cox-2).
is-sustanza taħdem billi timblokka enzima bl-isem ċiklossiġenażi 2 (cyclo-oxygenase 2, cox-2).

vedaprofen blocks an enzyme (cyclo-oxygenase) that is involved in the production of prostaglandins.
vedaprofen jimblokka enzim (cyclo-oxygenase) li għandu x’jaqsam mal-produzzjoni ta’ prostaglandins.

it works by blocking an enzyme called cyclo-oxygenase-2 (cox-2).
hija taħdem billi timblokka enzima msejjħa cyclo- oxygenase- 2 (cox- 2).

it works mainly by blocking an enzyme called cyclo-oxygenase-2 (cox- 2).
taħdem billi prinċipalment timblokka enzim imsejjaħ cyclo- oxygenase-2 (cox-2).

it works by blocking an enzyme called cyclo-oxygenase, which produces prostaglandins, substances that are involved in the inflammation process.
din taħdem billi timblokka l-enżima msejħa ċiklooksiġenażi, li tipproduċi l-prostaglandini, sustanzi involuti fil-proċess ta’ infjammazzjoni.

acetylsalicylic acid inhibits platelet aggregation by irreversible inhibition of prostaglandin cyclo-oxygenase and thus inhibits the generation of thromboxane a2, an inducer of platelet aggregation and vasoconstriction.
acetylsalicylic acid jinibixxi l-aggregazzjoni ta’ plejtlits permezz tal-inibizzjoni b’mod irriversibbli tal-prostaglandin cyclo-oxygenase u b’hekk jiġi inibit il-produzzjoni ta’ thromoxane a2, li hija s- sustanza li tikkawża l-aggregazzjoni tal-plejtlits u l-vasokostrizzjoni.

cimicoxib is a non-steroidal anti-inflammatory drug belonging to the coxib group and acting by selective inhibition of the enzyme cyclo-oxygenase 2.
cimicoxib huwa mediċina anti-infjammatorja mhux sterojdi li jappartjeni għal grupp coxib u jaġixxi billi jimpedixxi l-enzima cyclo-oxygenase 2 b’mod silettiv.

etoricoxib is an oral, selective cyclo-oxygenase-2 (cox-2) inhibitor within the clinical dose range.
etoricoxib huwa inibitur cyclo- oxygenase- 2 (cox- 2) selettiv orali fi ħdan il- medda tad- dożaġġ kliniku.

it is one of a family of medicines called cox-2 inhibitors (this is short for cyclo-oxygenase-2 inhibitors).
huwa wieħed minn familja ta’ mediċini li jissejħu inibituri cox-2 (titlu fil-qosor għal cyclo-oxygenase-2 inhibitors).

vedaprofen inhibits the prostaglandin synthesis enzyme system (cyclo-oxygenase enzyme) and thus possesses anti-inflammatory, antipyretic and analgesic properties.
vedaprofen iwaqqaf l- enżima li tagħmel il- prostaglandin (cyclo- oxygenase) u jippossedi kwalitajiet anti inflammatorji, anti piretiċi u analġesiċi.

in some patients with compromised renal function (e.g. dehydrated patients or elderly patients with compromised renal function) the co-administration of angiotensin ii receptor antagonists and agents that inhibit cyclo-oxygenase may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible.
f’xi pazjenti li għandhom il-funzjoni renali kompromessa (eż. pazjenti deidratati jew pazjenti anzjani b’funzjoni renali kompromessa), l-għoti flimkien ta’ antagonisti tar-riċettur ta’ angiotensin ii u mediċini li jinibixxu cyclo-oxygenase, jista’ jirriżulta f’deterjorament addizzjonali tal- funzjoni renali, li jinkludi l-possibbiltà ta’ insuffiċjenza akuta renali, li normalment tkun riversibbli.